Stay updated with breaking news from Brian Jankowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Jankowitz has more than 20 years of experience and he is widely known for his expertise in acute neurological disorders
Operator: Good day, ladies and gentlemen, and welcome to Surgalign Holdings 2023 First Quarter Results Conference Call and Webcast.
Surgalign Holdings, Inc., a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce today, the release of HOLO™ AI Insights for use in neurovascular research.
Surgalign (Nasdaq:SRGA) announced today that it released its HOLO AI Insights for use in neurovascular research.
Comaneci temporarily expands blood vessels-recognized as novel device for life-threatening disease Rapid Medical, a leading developer of advanced neurovascular devices, today announced FDA breakthrough